<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36109264</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2831</ISSN><JournalIssue CitedMedium="Internet"><Volume>28 Suppl 1</Volume><PubDate><Year>2022</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Radiography (London, England : 1995)</Title><ISOAbbreviation>Radiography (Lond)</ISOAbbreviation></Journal><ArticleTitle>Post-acute COVID syndrome (long COVID): What should radiographers know and the potential impact for imaging services.</ArticleTitle><Pagination><StartPage>S93</StartPage><EndPage>S99</EndPage><MedlinePgn>S93-S99</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.radi.2022.08.009</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1078-8174(22)00119-5</ELocationID><Abstract><AbstractText Label="OBJECTIVES">The COVID-19 pandemic caused an unprecedented health crisis resulting in over 6 million deaths worldwide, a figure, which continues to grow. In addition to the excess mortality, there are individuals who recovered from the acute stages, but suffered long-term changes in their health post COVID-19, commonly referred to as long COVID. It is estimated there are currently 1.8 million long COVID sufferers by May 2022 in the UK alone. The aim of this narrative literature review is to explore the signs, symptoms and diagnosis of long COVID and the potential impact on imaging services.</AbstractText><AbstractText Label="KEY FINDINGS">Long COVID is estimated to occur in 9.5% of those with two doses of vaccination and 14.6% if those with a single dose or no vaccination. Long COVID is defined by ongoing symptoms lasting for 12 or more weeks post acute infection. Symptoms are associated with reductions in the quality of daily life and may involve multisystem manifestations or present as a single symptom.</AbstractText><AbstractText Label="CONCLUSION">The full impact of long COVID on imaging services is yet to be realised, but there is likely to be significant increased demand for imaging, particularly in CT for the assessment of lung disease. Educators will need to include aspects related to long COVID pathophysiology and imaging presentations in curricula, underpinned by the rapidly evolving evidence base.</AbstractText><AbstractText Label="IMPLICATIONS FOR PRACTICE">Symptoms relating to long COVID are likely to become a common reason for imaging, with a particular burden on Computed Tomography services. Planning, education and updating protocols in line with a rapidly emerging evidence base is going to be essential.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alghamdi</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>College of Medicine and Health, University of Exeter, Exeter, UK. Electronic address: fa383@exeter.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Owen</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Human Sciences Research Centre, University of Derby, Derby, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashton</LastName><ForeName>R E M</ForeName><Initials>REM</Initials><AffiliationInfo><Affiliation>Human Sciences Research Centre, University of Derby, Derby, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Obotiba</LastName><ForeName>A D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>College of Medicine and Health, University of Exeter, Exeter, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meertens</LastName><ForeName>R M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>College of Medicine and Health, University of Exeter, Exeter, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hyde</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>College of Health, Psychology and Social Care, University of Derby, Derby, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faghy</LastName><ForeName>M A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Human Sciences Research Centre, University of Derby, Derby, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knapp</LastName><ForeName>K M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>College of Medicine and Health, University of Exeter, Exeter, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rogers</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Medical Imaging, Royal Devon and Exeter NHS Foundation Trust, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strain</LastName><ForeName>W D</ForeName><Initials>WD</Initials><AffiliationInfo><Affiliation>College of Medicine and Health, University of Exeter, Exeter, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Radiography (Lond)</MedlineTA><NlmUniqueID>9604102</NlmUniqueID><ISSNLinking>1078-8174</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Computed tomography</Keyword><Keyword MajorTopicYN="N">Imaging</Keyword><Keyword MajorTopicYN="N">Long-covid</Keyword><Keyword MajorTopicYN="N">Magnetic resonance imaging</Keyword><Keyword MajorTopicYN="N">Radiography</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>15</Day><Hour>22</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36109264</ArticleId><ArticleId IdType="pmc">PMC9468096</ArticleId><ArticleId IdType="doi">10.1016/j.radi.2022.08.009</ArticleId><ArticleId IdType="pii">S1078-8174(22)00119-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Li J., Long X., Wang X., Fang F., Lv X., Zhang D., et al. Radiology indispensable for tracking COVID-19. Diagn Interv Imaging. 2021;102:69&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7685040</ArticleId><ArticleId IdType="pubmed">33281082</ArticleId></ArticleIdList></Reference><Reference><Citation>Cozzi A., Schiaffino S., Arpaia F., Della Pepa G., Tritella S., Bertolotti P., et al. Chest x-ray in the COVID-19 pandemic: radiologists' real-world reader performance. Eur J Radiol. 2020;132</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7481070</ArticleId><ArticleId IdType="pubmed">32971326</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S., Zhang Y., Shen J., Dai Y., Ling Y., Lu H., et al. Clinical potential of UTE-MRI for assessing COVID-19: patient-and lesion-based comparative analysis. J&#xa0;Magn Reson Imaging. 2020;52:397&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7300684</ArticleId><ArticleId IdType="pubmed">32491257</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng S.M., Yang K.C., Chan W.P., Wang Y.W., Lin L.J., Yen A.M.F., et al. Impact of the COVID-19 pandemic on a population-based breast cancer screening program. Cancer. 2020;126:5202&#x2013;5205.</Citation><ArticleIdList><ArticleId IdType="pubmed">32914864</ArticleId></ArticleIdList></Reference><Reference><Citation>DeGroff A., Miller J., Sharma K., Sun J., Helsel W., Kammerer W., et al. COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January&#x2013;June 2020, in the United States. Prev Med. 2021;151</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9026719</ArticleId><ArticleId IdType="pubmed">34217410</ArticleId></ArticleIdList></Reference><Reference><Citation>Eijkelboom A.H., de Munck L., Lobbes M.B., van Gils C.H., Wesseling J., Westenend P.J., et al. Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic. Prev Med. 2021;151</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9755636</ArticleId><ArticleId IdType="pubmed">34217417</ArticleId></ArticleIdList></Reference><Reference><Citation>Leite H., Lindsay C., Kumar M. COVID-19 outbreak: implications on healthcare operations. TQM J. 2020;33(1):247&#x2013;256. doi: 10.1108/TQM-05-2020-0111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1108/TQM-05-2020-0111</ArticleId></ArticleIdList></Reference><Reference><Citation>National Health Service England NHS Improvement . NHS; 2019. NHS diagnostic waiting times and activity data.</Citation></Reference><Reference><Citation>Thakur V., Bhola S., Thakur P., Patel S.K.S., Kulshrestha S., Ratho R.K., et al. Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe. Infection. 2021:1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8675301</ArticleId><ArticleId IdType="pubmed">34914036</ArticleId></ArticleIdList></Reference><Reference><Citation>Burki T.K. Omicron variant and booster COVID-19 vaccines. Lancet Respir Med. 2022;10:e17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8683118</ArticleId><ArticleId IdType="pubmed">34929158</ArticleId></ArticleIdList></Reference><Reference><Citation>National Health Service Coronavirus (COVID-19) vaccine for people with a severely weakened immune system. 2022. https://www.nhs.uk/conditions/coronavirus-covid-19/coronavirus-vaccination/coronavirus-vaccine-people-with-severely-weakened-immune-system/ [Online]. Available:</Citation></Reference><Reference><Citation>Mahase E. Covid-19: what do we know about &#x201c;long covid&#x201d;? BMJ. 2020;370:m2815.</Citation><ArticleIdList><ArticleId IdType="pubmed">32665317</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg M., Maralakunte M., Garg S., Dhooria S., Sehgal I., Bhalla A.S., et al. The conundrum of &#x2018;long-COVID-19&#x2019;: a narrative review. Int J Gen Med. 2021;14:2491&#x2013;2506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8214209</ArticleId><ArticleId IdType="pubmed">34163217</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F., Perego E. How and why patients made long Covid. Soc Sci Med. 2021;268</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 7 July 2022. 2022. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/7july2022 [Online]. Available:</Citation></Reference><Reference><Citation>NICE . National Institute of Health Care Excellence; 2020. COVID-19 rapid guideline: managing the long-term effects of COVID-19 NICE guideline [NG188]</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Department of Health &amp; Human Services  Guidance on &#x201c;long COVID&#x201d; as a disability under the ADA, section 504, and section 1557. 2021. https://www.hhs.gov/civil-rights/for-providers/civil-rights-covid19/guidance-long-covid-disability/index.html#footnote10_0ac8mdc [Online]. Available:</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention  New ICD-10-CM code for post-COVID conditions, following the 2019 novel coronavirus (COVID-19) 2021. https://www.cdc.gov/nchs/icd/icd10cm.htm [Online]. Available:</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention . 2021. Post-COVID conditions. [Online]</Citation></Reference><Reference><Citation>National Institute for Health and Care Excellence  COVID-19 rapid guideline: managing the longterm effects of COVID-19. 2021. https://www.nice.org.uk/guidance/ng188/resources/covid19-rapid-guideline-managing-the-longterm-effects-of-covid19-pdf-51035515742 [Online]. Available:</Citation><ArticleIdList><ArticleId IdType="pubmed">34181371</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics Self-reported long COVID after two doses of a coronavirus (COVID-19) vaccine in the UK: 26 January 2022. 2022. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/selfreportedlongcovidaftertwodosesofacoronaviruscovid19vaccineintheuk/26january2022 [Online]. Available:</Citation></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Weerahandi H., Hochman K.A., Simon E., Blaum C., Chodosh J., Duan E., et al. Post-discharge health status and symptoms in patients with severe COVID-19. J&#xa0;Gen Intern Med. 2021;36:738&#x2013;745.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808113</ArticleId><ArticleId IdType="pubmed">33443703</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B., Mohn K.G., Brokstad K.A., Zhou F., Linchausen D.W., Hansen B.A., et al. Long COVID in a prospective cohort of home-isolated patients. Nat Med. 2021;27:1607&#x2013;1613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans R.A., Leavy O.C., Richardson M., Elneima O., McAuley H.J., Shikotra A., et al. medRxiv; 2021. Clinical characteristics with inflammation profiling of Long-COVID and association with one-year recovery following hospitalisation in the UK: a prospective observational study.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E., Janvier P., Kherabi Y., Le Bot A., Hamon A., Gouze H., et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J&#xa0;Infect. 2020;81:e4&#x2013;e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Solve M.E. Long COVID: nearly 7% of U.S. Adults suffering symptoms; personal financial burden estimated at $386 billion. 2022. https://www.prnewswire.com/news-releases/long-covid-nearly-7-of-us-adults-suffering-symptoms-personal-financial-burden--estimated-at-386-billion-301517095.html [Online]. Available:</Citation></Reference><Reference><Citation>National Institute for Health Research  Living with Covid19. A dynamic review of the evidence around ongoing Covid19 symptoms (often called Long Covid) 2020. https://evidence.nihr.ac.uk/themedreview/living-with-covid19/ [Online]. Available:</Citation></Reference><Reference><Citation>Yong S.J., Liu S. Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapies. Rev Med Virol. 2021:e2315.</Citation><ArticleIdList><ArticleId IdType="pubmed">34888989</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker R.C. Springer; 2021. COVID-19 and its sequelae: a platform for optimal patient care, discovery and training.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7838017</ArticleId><ArticleId IdType="pubmed">33501596</ArticleId></ArticleIdList></Reference><Reference><Citation>Boix V., Merino E. Post-COVID syndrome. The never ending challenge. Med Clin. 2022;158:178&#x2013;180.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8801902</ArticleId><ArticleId IdType="pubmed">35128063</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A., Jayadevan R., Sashidharan S. Long COVID: an overview. Diabetes Metabol Syndr Clin Res Rev. 2021;15:869&#x2013;875.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9637465</ArticleId><ArticleId IdType="pubmed">36351871</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes L.D., Ingram J., Sculthorpe N.F. More than 100 persistent symptoms of SARS-CoV-2 (long COVID): a scoping review. Front Med. 2021;2028</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8591053</ArticleId><ArticleId IdType="pubmed">34790680</ArticleId></ArticleIdList></Reference><Reference><Citation>National Health Service Long-term effects of coronavirus (long COVID) https://www.nhs.uk/conditions/coronavirus-covid-19/long-term-effects-of-coronavirus-long-covid/ [Online]. Available:</Citation></Reference><Reference><Citation>Havervall S., Rosell A., Phillipson M., Mangsbo S.M., Nilsson P., Hober S., et al. Symptoms and functional impairment assessed 8 Months after mild COVID-19 among health care workers. JAMA. 2021;325:2015&#x2013;2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8027932</ArticleId><ArticleId IdType="pubmed">33825846</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce J.D., Shen Q., Cintron S.A., Hiebert J.B. Post-COVID-19 syndrome. Nurs Res. 2022;71:164&#x2013;174.</Citation><ArticleIdList><ArticleId IdType="pubmed">34653099</ArticleId></ArticleIdList></Reference><Reference><Citation>Tay M.Z., Poh C.M., R&#xe9;nia L., MacAry P.A., Ng L.F. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020;20:363&#x2013;374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7187672</ArticleId><ArticleId IdType="pubmed">32346093</ArticleId></ArticleIdList></Reference><Reference><Citation>Tehrani H.A., Darnahal M., Nadji S.A., Haghighi S. COVID-19 re-infection or persistent infection in patient with acute myeloid leukaemia M3: a mini review. New Microbes New infect. 2021;39</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7777517</ArticleId><ArticleId IdType="pubmed">33425365</ArticleId></ArticleIdList></Reference><Reference><Citation>Stam H., Stucki G., Bickenbach J. Covid-19 and post intensive care syndrome: a call for action. J&#xa0;Rehabil Med. 2020;52(4):1&#x2013;4. doi: 10.2340/16501977-2677.</Citation><ArticleIdList><ArticleId IdType="doi">10.2340/16501977-2677</ArticleId><ArticleId IdType="pubmed">32286675</ArticleId></ArticleIdList></Reference><Reference><Citation>Gal&#xe1;n M., Vig&#xf3;n L., Fuertes D., Murciano-Ant&#xf3;n M.A., Casado G., Dom&#xed;nguez-Mateos S., et al. Persistent overactive cytotoxic immune response in a Spanish cohort of individuals with Long-COVID: Identification of diagnostic biomarkers. Front Immunol. 2022;13:1129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8990790</ArticleId><ArticleId IdType="pubmed">35401523</ArticleId></ArticleIdList></Reference><Reference><Citation>Arostegui D., Castro K., Schwarz S., Vaidy K., Rabinowitz S., Wallach T. Persistent SARS-CoV-2 nucleocapsid protein presence in the intestinal epithelium of a pediatric patient 3 months after acute infection. JPGN Rep. 2022;3:e152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10158423</ArticleId><ArticleId IdType="pubmed">37168753</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239&#x2013;1242.</Citation><ArticleIdList><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A., Madhavan M.V., Sehgal K., Nair N., Mahajan S., Sehrawat T.S., et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26:1017&#x2013;1032.</Citation><ArticleIdList><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Vlok M., Venter C., Bezuidenhout J.A., Laubscher G.J., Steenkamp J., et al. Persistent clotting protein pathology in long COVID/post-acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol. 2021;20:1&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva Andrade B., Siqueira S., de Assis Soares W.R., de Souza Rangel F., Santos N.O., dos Santos Freitas A., et al. Long-COVID and post-COVID health complications: an up-to-date review on clinical conditions and their possible molecular mechanisms. Viruses. 2021;13:700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8072585</ArticleId><ArticleId IdType="pubmed">33919537</ArticleId></ArticleIdList></Reference><Reference><Citation>Grist J.T., Chen M., Collier G.J., Raman B., AbuEid G., McIntyre A., et al. Hyperpolarized 129Xe MRI abnormalities in dyspneic patients 3 Months after COVID-19 pneumonia: preliminary results. Radiology. 2021;301:E353&#x2013;E360.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8168952</ArticleId><ArticleId IdType="pubmed">34032513</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollini M., Morbelli S., Ciccarelli M., Cecconi M., Aghemo A., Morelli P., et al. Long COVID hallmarks on [18F] FDG-PET/CT: a case-control study. Eur J Nucl Med Mol Imaging. 2021;48:3187&#x2013;3197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7937050</ArticleId><ArticleId IdType="pubmed">33677642</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacques Hugon M.Q., Sanchez Ortiz Marta, Flore Msika Eva, Farid Karim, Paquet Claire. Cognitive decline and brainstem hypometabolism in long COVID: a case series. Brain Behav. 2022;12(4):1&#x2013;5. doi: 10.1002/brb3.2513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.2513</ArticleId><ArticleId IdType="pmc">PMC9014998</ArticleId><ArticleId IdType="pubmed">35290729</ArticleId></ArticleIdList></Reference><Reference><Citation>Brosnahan S.B., Jonkman A.H., Kugler M.C., Munger J.S., Kaufman D.A. COVID-19 and respiratory system disorders: current knowledge, future clinical and translational research questions. Arterioscler Thromb Vasc Biol. 2020;40:2586&#x2013;2597.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7571846</ArticleId><ArticleId IdType="pubmed">32960072</ArticleId></ArticleIdList></Reference><Reference><Citation>Faghy M.A., Maden-Wilkinson T., Arena R., Copeland R.J., Owen R., Hodgkins H., et al. COVID-19 patients require multi-disciplinary rehabilitation approaches to address persisting symptom profiles and restore pre-COVID quality of life. Expet Rev Respir Med. 2022;16:1&#x2013;6. doi: 10.1080/17476348.2022.2063843.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17476348.2022.2063843</ArticleId><ArticleId IdType="pubmed">35385677</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F., Kream R.M., Stefano G.B. Long-term respiratory and neurological sequelae of COVID-19. Med Sci Monit. 2020;26 e928996-928991.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7643287</ArticleId><ArticleId IdType="pubmed">33177481</ArticleId></ArticleIdList></Reference><Reference><Citation>Cereda A., Toselli M., Palmisano A., Leone R., Vignale D., Nicoletti V., et al. Is pleural effusion in COVID-19 interstitial pneumonia related to in-hospital mortality? Ital J Med. 2021;15</Citation></Reference><Reference><Citation>Eapen M.S., Lu W., Gaikwad A.V., Bhattarai P., Chia C., Hardikar A., et al. Endothelial to mesenchymal transition: a precursor to post-COVID-19 interstitial pulmonary fibrosis and vascular obliteration? Eur Respir J. 2020;56</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7453738</ArticleId><ArticleId IdType="pubmed">32859681</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells A.U., Devaraj A., Desai S.R. Radiological Society of North America; 2021. Interstitial lung disease after COVID-19 infection: a catalog of uncertainties.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7841875</ArticleId><ArticleId IdType="pubmed">33502279</ArticleId></ArticleIdList></Reference><Reference><Citation>Barisione G., Brusasco V. Lung diffusing capacity for nitric oxide and carbon monoxide following mild-to-severe COVID-19. Physiol Rep. 2021;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7903940</ArticleId><ArticleId IdType="pubmed">33625799</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas M., Price O.J., Hull J.H. Pulmonary function and COVID-19. Curr Opin Physiol. 2021;21:29&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7997144</ArticleId><ArticleId IdType="pubmed">33817453</ArticleId></ArticleIdList></Reference><Reference><Citation>Froidure A., Mahsouli A., Liistro G., De Greef J., Belkhir L., G&#xe9;rard L., et al. Integrative respiratory follow-up of severe COVID-19 reveals common functional and lung imaging sequelae. Respir Med. 2021;181</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8019490</ArticleId><ArticleId IdType="pubmed">33839588</ArticleId></ArticleIdList></Reference><Reference><Citation>Cort&#xe9;s-Telles A., L&#xf3;pez-Romero S., Figueroa-Hurtado E., Pou-Aguilar Y.N., Wong A.W., Milne K.M., et al. Pulmonary function and functional capacity in COVID-19 survivors with persistent dyspnoea. Respir Physiol Neurobiol. 2021;288</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7910142</ArticleId><ArticleId IdType="pubmed">33647535</ArticleId></ArticleIdList></Reference><Reference><Citation>Timurkaan M., Altuntas G., Kalayci M., Timurkaan E.S., Ayyildiz H. Early warning triad for pulmonary microemboli in COVID-19 pneumonia: pulmonary artery diameter, D-dimer and NT-proBNP. Medicine. 2022;11:775&#x2013;779.</Citation></Reference><Reference><Citation>Nabavi N. Long covid: how to define it and how to manage it. BMJ. 2020;370:m3489. doi: 10.1136/bmj.m3489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3489</ArticleId><ArticleId IdType="pubmed">32895219</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes D.L., Holdsworth L., Jawad N., Gunasekera P., Morice A.H., Crooks M.G. Post-COVID-19 symptom burden: what is long-COVID and how should we manage it? Lung. 2021;199:113&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaarslan F., Guneri F.D., Kardes S. Long COVID: rheumatologic/musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6 months. Clin Rheumatol. 2022;41:289&#x2013;296.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8553494</ArticleId><ArticleId IdType="pubmed">34713356</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M., Palese A., Venturini M., De Martino M., Gerussi V., Graziano E., et al. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect. 2021;27:1507&#x2013;1513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosn J., Piroth L., Epaulard O., Le Turnier P., Mentr&#xe9; F., Bachelet D., et al. Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort. Clin Microbiol Infect. 2021;27:1041. 1041.e1-1041.e4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8107834</ArticleId><ArticleId IdType="pubmed">34125067</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaishya R., Jain V.K., Iyengar K.P. Musculoskeletal manifestations of COVID-19. J&#xa0;Clin Orthop Trauma. 2021;17:280&#x2013;281.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7935681</ArticleId><ArticleId IdType="pubmed">33716426</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E., Million M., Dudouet P., Tissot-Dupont H., Bregeon F., Cammilleri S., et al. 18F-FDG brain PET hypometabolism in post-SARS-CoV-2 infection: substrate for persistent/delayed disorders? Eur J Nucl Med Mol Imaging. 2021;48:592&#x2013;595.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7391029</ArticleId><ArticleId IdType="pubmed">32728799</ArticleId></ArticleIdList></Reference><Reference><Citation>Wostyn P. COVID-19 and chronic fatigue syndrome: is the worst yet to come? Med Hypotheses. 2021;146</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7836544</ArticleId><ArticleId IdType="pubmed">33401106</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks S.K., Webster R.K., Smith L.E., Woodland L., Wessely S., Greenberg N., et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020;395:912&#x2013;920.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7158942</ArticleId><ArticleId IdType="pubmed">32112714</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed S., Akter R., Islam M.J., Muthalib A.A., Sadia A.A. Impact of lockdown on musculoskeletal health due to COVID-19 outbreak in Bangladesh: a cross sectional survey study. Heliyon. 2021;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8217068</ArticleId><ArticleId IdType="pubmed">34179540</ArticleId></ArticleIdList></Reference><Reference><Citation>Collet P., Uebelhart D., Vico L., Moro L., Hartmann D., Roth M., et al. Effects of 1-and 6-month spaceflight on bone mass and biochemistry in two humans. Bone. 1997;20:547&#x2013;551.</Citation><ArticleIdList><ArticleId IdType="pubmed">9177869</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwamoto J., Takeda T., Sato Y. Interventions to prevent bone loss in astronauts during space flight. Keio J Med. 2005;54:55&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">16077253</ArticleId></ArticleIdList></Reference><Reference><Citation>Sibonga J.D., Spector E.R., Johnston S.L., Tarver W.J. Evaluating bone loss in ISS astronauts. Aerosp Med Hum Perform. 2015;86:A38&#x2013;A44.</Citation><ArticleIdList><ArticleId IdType="pubmed">26630194</ArticleId></ArticleIdList></Reference><Reference><Citation>Knapp K.M., Rowlands A.V., Welsman J.R., MacLeod K.M. Prolonged unilateral disuse osteopenia 14 years post external fixator removal: a case history and critical review. Case Rep Med. 2010;2010</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2858376</ArticleId><ArticleId IdType="pubmed">20445732</ArticleId></ArticleIdList></Reference><Reference><Citation>Gundry M., Hopkins S., Knapp K. A&#xa0;review on bone mineral density loss in total knee replacements leading to increased fracture risk. Clin Rev Bone Miner Metabol. 2017;15:162&#x2013;174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5698368</ArticleId><ArticleId IdType="pubmed">29213219</ArticleId></ArticleIdList></Reference><Reference><Citation>Poole K.E., Warburton E.A., Reeve J. Rapid long-term bone loss following stroke in a man with osteoporosis and atherosclerosis. Osteoporos Int. 2005;16:302&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pubmed">15197547</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins S., Toms A., Brown M., Welsman J., Ukoumunne O., Knapp K. A&#xa0;study investigating short-and medium-term effects on function, bone mineral density and lean tissue mass post-total knee replacement in a Caucasian female post-menopausal population: implications for hip fracture risk. Osteoporos Int. 2016;27:2567&#x2013;2576.</Citation><ArticleIdList><ArticleId IdType="pubmed">26919995</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao W., Lau H.E., Xie H., Poon V.K.M., Chan C.C.S., Chu H., et al. SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamsters. Nat Commun. 2022;13(1):1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9085785</ArticleId><ArticleId IdType="pubmed">35534483</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao H., Ge G., Li W., Liang X., Wang H., Li N., et al. Dysimmunity and inflammatory storm: watch out for bone lesions in COVID-19 infection. Med Hypotheses. 2020;145</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7536122</ArticleId><ArticleId IdType="pubmed">33039950</ArticleId></ArticleIdList></Reference><Reference><Citation>Kottlors J., Hokamp N.G., Fervers P., Bremm J., Fichter F., Persigehl T., et al. Early extrapulmonary prognostic features in chest computed tomography in COVID-19 pneumonia: bone mineral density is a relevant predictor for the clinical outcome &#x2013; a multicenter feasibility study. Bone. 2021;144</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7720732</ArticleId><ArticleId IdType="pubmed">33301962</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckley L., Humphrey M.B. Glucocorticoid-induced osteoporosis. N&#xa0;Engl J Med. 2018;379:2547&#x2013;2556.</Citation><ArticleIdList><ArticleId IdType="pubmed">30586507</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang J. What can we learn about corticosteroid therapy as a treatment for COVID-19? Osteoporos Int. 2020;vol. 31 1595-1595.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7282726</ArticleId><ArticleId IdType="pubmed">32519174</ArticleId></ArticleIdList></Reference><Reference><Citation>Baimukhamedov C., Barskova T., Matucci-Cerinic M. Arthritis after SARS-CoV-2 infection. Lancet Rheumatol. 2021;3:e324&#x2013;e325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7963449</ArticleId><ArticleId IdType="pubmed">33748780</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukarram M.S., Ishaq Ghauri M., Sethar S., Afsar N., Riaz A., Ishaq K. COVID-19: an emerging culprit of inflammatory arthritis. Case Rep Rheumatol. 2021;2021</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8077721</ArticleId><ArticleId IdType="pubmed">33986966</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdullahi A., Candan S.A., Abba M.A., Bello A.H., Alshehri M.A., Afamefuna Victor E., et al. Neurological and musculoskeletal features of COVID-19: a systematic review and meta-analysis. Front Neurol. 2020;687</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7333777</ArticleId><ArticleId IdType="pubmed">32676052</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-de-Las-Penas C., de-la-Llave-Rincon A.I., Ortega-Santiago R., Ambite-Quesada S., Gomez-Mayordomo V., Cuadrado M.L., et al. Prevalence and risk factors of musculoskeletal pain symptoms as long-term post-COVID sequelae in hospitalized COVID-19 survivors: a multicenter study. Pain. 2021;163(9):e989&#x2013;e996. doi: 10.1097/j.pain.0000000000002564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002564</ArticleId><ArticleId IdType="pubmed">34913880</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramani S.L., Samet J., Franz C.K., Hsieh C., Nguyen C.V., Horbinski C., et al. Musculoskeletal involvement of COVID-19: review of imaging. Skeletal Radiol. 2021;50:1763&#x2013;1773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7889306</ArticleId><ArticleId IdType="pubmed">33598718</ArticleId></ArticleIdList></Reference><Reference><Citation>Gualtieri P., Falcone C., Romano L., Macheda S., Correale P., Arciello P., et al. Body composition findings by computed tomography in SARS-CoV-2 patients: increased risk of muscle wasting in obesity. Int J Mol Sci. 2020;21:4670.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7370146</ArticleId><ArticleId IdType="pubmed">32630032</ArticleId></ArticleIdList></Reference><Reference><Citation>Willoughby D., Hewlings S., Kalman D. Body composition changes in weight loss: strategies and supplementation for maintaining lean body mass, a brief review. Nutrients. 2018;10:1876.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6315740</ArticleId><ArticleId IdType="pubmed">30513859</ArticleId></ArticleIdList></Reference><Reference><Citation>Knapp K. Dual energy X-ray absorptiometry: beyond bone mineral density. Imaging Ther Pract. 2015;5</Citation></Reference><Reference><Citation>Backhaus T.M., Ohrndorf S., Kellner H., Strunk J., Hartung W., Sattler H., et al. The US7 score is sensitive to change in a large cohort of patients with rheumatoid arthritis over 12 months of therapy. Ann Rheum Dis. 2013;72:1163&#x2013;1169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3686255</ArticleId><ArticleId IdType="pubmed">22956596</ArticleId></ArticleIdList></Reference><Reference><Citation>National Health Service England and NHS Improvement coronavirus  National Guidance for post-COVID syndrome assessment clinics. 2021. https://www.england.nhs.uk/coronavirus/documents/national-guidance-for-post-covid-syndrome-assessment-clinics/ [Online]. 2022. Available: [accessed March, 22]</Citation></Reference><Reference><Citation>Han J.H., Womack K.N., Tenforde M.W., Files D.C., Gibbs K.W., Shapiro N.I., et al. Associations between persistent symptoms after mild COVID-19 and long-term health status, quality of life, and psychological distress. Influenza Other Respir Viruses. 2022;16(4):680&#x2013;689. doi: 10.1111/irv.12980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.12980</ArticleId><ArticleId IdType="pmc">PMC9111447</ArticleId><ArticleId IdType="pubmed">35347854</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkodaymi M.S., Omrani O.A., Fawzy N.A., Abou Shaar B., Almamlouk R., Riaz M., et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Infect. 2022;28(5):657&#x2013;666.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8812092</ArticleId><ArticleId IdType="pubmed">35124265</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M., Halpin S., Gee J. Assessing long-term rehabilitation needs in COVID-19 survivors using a telephone screening tool (C19-YRS tool) Adv Clin Neurosci Rehabil. 2020;19:14&#x2013;17.</Citation></Reference><Reference><Citation>Baraniuk C. Covid-19: how Europe is approaching long covid. BMJ. 2022:376.</Citation><ArticleIdList><ArticleId IdType="pubmed">35058230</ArticleId></ArticleIdList></Reference><Reference><Citation>National Health Service Long COVID patients to get help at more than 60 clinics. 2020. https://www.england.nhs.uk/2020/12/long-covid-patients-to-get-help-at-more-than-60-clinics/ [Online]. Available:</Citation></Reference><Reference><Citation>Sis&#xf3;-Almirall A., Brito-Zer&#xf3;n P., Conangla Ferr&#xed;n L., Kostov B., Moragas Moreno A., Mestres J., et al. Long Covid-19: proposed primary care clinical guidelines for diagnosis and disease management. Int J Environ Res Public Health. 2021;18:4350.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8073248</ArticleId><ArticleId IdType="pubmed">33923972</ArticleId></ArticleIdList></Reference><Reference><Citation>Alarc&#xf3;n-Rodr&#xed;guez J., Fern&#xe1;ndez-Velilla M., Ure&#xf1;a-Vacas A., Mart&#xed;n-Pinacho J., Rigual-Bobillo J., Jauregu&#xed;zar-Oriol A., et al. Radiological management and follow-up of post-COVID-19 patients. Radiolog&#xed;a. 2021;63:258&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7914006</ArticleId><ArticleId IdType="pubmed">35370314</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Knight M., Buxton M., Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020:370.</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Society B.T. British Thoracic Society guidance on respiratory follow up of patients with a clinico-radiological diagnosis of COVID-19 pneumonia. Br Thorac Soc. 2020:1&#x2013;15.</Citation></Reference><Reference><Citation>National Institute for Health and Care Excellence  COVID-19 rapid guideline: managing the longterm effects of COVID-19. 2022. https://www.nice.org.uk/guidance/ng188 [Online]. Available:</Citation><ArticleIdList><ArticleId IdType="pubmed">34181371</ArticleId></ArticleIdList></Reference><Reference><Citation>Cau R., Faa G., Nardi V., Balestrieri A., Puig J., Suri J.S., et al. Long-COVID diagnosis: from diagnostic to advanced AI-driven models. Eur J Radiol. 2022;148</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8791239</ArticleId><ArticleId IdType="pubmed">35114535</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>